A Shared-Value Model for Enhancing Diabetes Care in South Africa

By Rene Pretorius

April 4, 2025

Summary

In a world where diabetes management demands both innovation and integration, DiaCision is at the forefront, using AI-driven insights to improve outcomes and reshape the way care is delivered. As we look for transformative models that go beyond traditional approaches, the article “Improving Diabetes Care in South Africa Through a Shared-Value Model” offers an important case study.

This piece reviews a program by Discovery Health, launched in 2021, that aims to enhance diabetes care in South Africa through a shared-value approach. By focusing on improving hemoglobin A1c testing rates, glycemic control, and disease stability, the program has demonstrated measurable success over three years. Notably, it has also contributed to reduced hospital admissions and healthcare costs. In the broader context of advancing diabetes care, this model presents a compelling example of how aligning patient outcomes with system-wide value can lead to scalable, sustainable impact.

Key Insights

  • Shared-Value Model: The program incentivizes medical practitioners to improve diabetes care, leading to better patient outcomes.
  • Glycemic Control and Stability: HbA1c testing rates, glycemic control, and disease stability improved notably.
  • Economic Benefits: Hospital admissions and healthcare costs decreased, suggesting long-term savings.

Background Context

Diabetes is a major global health challenge. The WHO highlights its rising prevalence and the need for effective management. In South Africa, healthcare access varies. Shared-value programs can help bridge gaps in diabetes care in South Africa. The WHO stresses cost-effective interventions that prioritize patient outcomes, aligning with shared-value models.

Implications

This shared-value model has significant implications:

  • Healthcare Cost Reduction: Better diabetes management reduces admissions and costs.
  • Improved Patient Outcomes: Enhanced glycemic control and stability reduce complications and improve quality of life.
  • Scalability and Adaptability: Such programs can inspire similar initiatives elsewhere, aiding broader healthcare reform.

The content highlights innovative healthcare models’ role in improving patient outcomes. Insights from value-based care discussions suggest these models are key to better health outcomes and cost control. For more details, see the original article here.

Reference url

Recent Posts

Boosting Africa Vaccine Manufacturing: A New Era of Local Production and Supply Security

By João L. Carapinha

May 15, 2026

Africa Vaccine Manufacturing stands to benefit from ongoing talks between Africa CDC and Aspen Pharmacare aimed at securing long-term vaccine supply agreements that strengthen local production capacity across the continent. The discussions focus on selecting priority antigens, scaling annual outp...
NICE Approves Durvalumab for Gastric Cancer Treatment
NICE has issued final draft guidance recommending durvalumab, within its marketing authorisation, for use with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy as neoadjuvant and adjuvant treatment, followed by durvalumab monotherapy as adjuvant treatment, in adults with ...
Key Strategies in Neonatal Infection Management: Insights from NICE Guideline NG195

By João L. Carapinha

May 13, 2026

The NICE guideline NG195 establishes a structured framework for neonatal infection management in newborns up to 28 days corrected gestational age, treating at-risk pregnant individuals, and managing suspected or confirmed infections in neonates. It emphasizes timely recognition to avoid delays, j...